Search by Drug Name or NDC
NDC 00641-6246-10 IMMPHENTIV 100 ug/mL Details
IMMPHENTIV 100 ug/mL
IMMPHENTIV is a INTRAVENOUS INJECTABLE, LIPOSOMAL in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Hikma Pharmaceuticals USA Inc.. The primary component is PHENYLEPHRINE HYDROCHLORIDE.
Product Information
| NDC | 00641-6246 |
|---|---|
| Product ID | 0641-6246_9861867e-7680-4bad-9740-fdb1b9c5c242 |
| Associated GPIs | |
| GCN Sequence Number | 085500 |
| GCN Sequence Number Description | phenylephrine HCl VIAL 0.1 MG/ML INTRAVEN |
| HIC3 | J5E |
| HIC3 Description | SYMPATHOMIMETIC AGENTS |
| GCN | 55002 |
| HICL Sequence Number | 002087 |
| HICL Sequence Number Description | PHENYLEPHRINE HCL |
| Brand/Generic | Brand |
| Proprietary Name | IMMPHENTIV |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Phenylephrine Hydrochloride |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | INJECTABLE, LIPOSOMAL |
| Route | INTRAVENOUS |
| Active Ingredient Strength | 100 |
| Active Ingredient Units | ug/mL |
| Substance Name | PHENYLEPHRINE HYDROCHLORIDE |
| Labeler Name | Hikma Pharmaceuticals USA Inc. |
| Pharmaceutical Class | Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC] |
| DEA Schedule | n/a |
| Marketing Category | NDA |
| Application Number | NDA203826 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 00641-6246-10 (00641624610)
| NDC Package Code | 0641-6246-10 |
|---|---|
| Billing NDC | 00641624610 |
| Package | 10 VIAL in 1 CARTON (0641-6246-10) / 10 mL in 1 VIAL |
| Marketing Start Date | 2023-03-09 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |